Inovio Pharmaceuticals OverviewInovio Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for INO.
Quarterly Other Income/Expense
$2.27M
↓ 99.96% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$1.87B
↓ 77.96% YoY
Trailing 12 months ending Mar 31, 2026